Menu
Back to Journals » Biologics: Targets and Therapy » Volume 14 » default
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (502)
- Volume 18, 2024 (6)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 14, 2020
Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report
Daham N, AlMuqrin A, Madani A, AlSaif F
Biologics: Targets and Therapy 2020, 14:127-129
Published Date: 11 November 2020
Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study
Pedersen L, Szecsi PB, Johansen PB, Bjerrum PJ
Biologics: Targets and Therapy 2020, 14:115-125
Published Date: 29 October 2020
Glycopeptides as Potential Interventions for COVID-19
Demsie DG, Gebre AK, Yimer EM, Alema NM, Araya EM, Bantie AT, Allene MD, Gebremedhin H, Yehualaw A, Tafere C, Tadese HT, Amare B, Weldekidan E, Gebrie D
Biologics: Targets and Therapy 2020, 14:107-114
Published Date: 13 October 2020
Nucleic Acid Therapy for β-Thalassemia
d'Arqom A
Biologics: Targets and Therapy 2020, 14:95-105
Published Date: 15 September 2020
Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration
Akyol E, Lotery A
Biologics: Targets and Therapy 2020, 14:83-94
Published Date: 11 September 2020
A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment
Wondmkun YT, Mohammed OA
Biologics: Targets and Therapy 2020, 14:77-82
Published Date: 25 August 2020
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
Chimenti MS, D'Antonio A, Conigliaro P, Ferrigno S, Vendola A, Ferraioli M, Triggianese P, Costa L, Caso F, Perricone R
Biologics: Targets and Therapy 2020, 14:53-75
Published Date: 20 August 2020
Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
Marafini I, Monteleone G
Biologics: Targets and Therapy 2020, 14:47-51
Published Date: 15 June 2020
Galanin Receptors as Drug Target for Novel Antidepressants: Review
Demsie DG, Altaye BM, Weldekidan E, Gebremedhin H, Alema NM, Tefera MM, Bantie AT
Biologics: Targets and Therapy 2020, 14:37-45
Published Date: 21 April 2020
Autophagy Regulates the Stemness of Cervical Cancer Stem Cells [Retraction]
Yang Y, Yu L, Li J, Yuan YH, Wang XL, Yan SR, Li DS, Ding Y
Biologics: Targets and Therapy 2020, 14:35-36
Published Date: 26 March 2020
Blinatumomab for the Treatment of Adult B-Cell Acute Lymphoblastic Leukemia: Toward a New Era of Targeted Immunotherapy
Franquiz MJ, Short NJ
Biologics: Targets and Therapy 2020, 14:23-34
Published Date: 14 February 2020
Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
Cimmino MA, Parodi M, Barbieri F, Bombardieri S, Zampogna G, Iagnocco A, Batticciotto A, Sconfienza LM, Sinigaglia L, De Benedetti F, Atzeni F, Sarzi-Puttini P
Biologics: Targets and Therapy 2020, 14:13-21
Published Date: 11 February 2020
Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
Al Sulais E, AlAmeel T
Biologics: Targets and Therapy 2020, 14:1-11
Published Date: 10 January 2020